investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Johan Spetz
- CFO and Head of Investor Relations
- ir@sedanamedical.com
The Share
Press Releases
2026
2026-04-24 14:00
The board of directors of Sedana Medical AB (publ) has resolved to convene an annual general meeting of shareholders to be held Wednesday, 27 May 2026...
2026-04-23 07:00
Positive Group EBITDA despite market headwinds First quarter 2026 CEO comments Positive Group EBITDA despite market headwinds In the first quarter of 2026...
2026-04-14 18:00
Sedana Medical AB’s (publ) Annual Report describes important events and financial information for 2025, as well as the progress the company has made...
Financial Reports
Financial Calendar
Latest Presentation
No presentations found.
